CrushSCI.com
91.4Average days
79Median days
2Fastest days
277Longest days
1,5802025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

3 days

From predicting myopia progression to identifying treatment benefit: interpreting choroidal remodeling during atropine therapy

Authors
Jing ChenShow moreShow less
Affiliations
1. Department of Ophthalmology, People’s Hospital of Leshan, Leshan, ChinaShow moreShow less
Source PDF DOI Publisher page
61 days

Hemostatic complications after CAR T-cell therapy: linking immunothrombotic mechanisms to phase-adapted management

Authors
Xumeng Zhao; Shuai Su; Jiaying Wu; Yi XiaoShow moreShow less
Affiliations
1. Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaShow moreShow less
Source PDF DOI Publisher page
77 days

Histology-related clinical significance of artificial intelligence-assisted multiplex immunofluorescence features in rectal mucinous and non-mucinous adenocarcinoma

Authors
Ke Zhao; Karolina Vernmark; Annika Knutsen; Yajun Li; Charlotte Stadler; Chuanwen Fan; Xiao-Feng SunShow moreShow less
Affiliations
1. Chinese Medicine Guangdong Laboratory, Zhuhai, China; 2. Department of Oncology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; 3. Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People’s Hospital, Guangzhou, China; 4. SciLifeLab, Department of Protein Science, KTH Royal Institute of Technology, Solna, Sweden; 5. Division of Gastrointestinal, Bariatric & Metabolic Surgery, Department of General Surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, ChinaShow moreShow less
Source PDF DOI Publisher page
108 days

Macrophage polarization in the pathogenesis of myocardial fibrosis in chronic kidney disease: mechanisms and therapeutic prospects

Authors
Han Li; Hailing Zhao; Feihong Ren; Qi Jin; Yuhang Qiao; Liping Yang; Fang Ma; Yuyang Wang; Ping Li; Yongli Zhan; Huimin MaoShow moreShow less
Affiliations
1. Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China; 2. Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, ChinaShow moreShow less
Source PDF DOI Publisher page
123 days

Anti-IL-23 and anti-IL-17 therapies reshape immune-adipose crosstalk in psoriasis: exploratory evidence implicating visfatin as a key inflammatory mediator in obese patients

Authors
Maria Grazia Lolli; Luca Sanna; Mario Picozza; Fernanda Scopelliti; Roberta Belli; Claudia Scarponi; Gianluca Pagnanelli; Francesca Sampogna; Gaia Moretta; Ezio Nicodemi; Anna Dattolo; Matteo Megna; Melania Parisi; Andrea Cavani; Cristina Albanesi; Stefania Madonna; Laura MercurioShow moreShow less
Affiliations
1. Laboratory of Experimental Immunology, Istituto Dermopatico dell’Immacolata IDI-IRCCS, Rome, Italy; 2. Core Facilities, Cytometry Area, Istituto Superiore di Sanità, Rome, Italy; 3. National Institute for Health, Migration and Poverty INMP/NIHMP, Rome, Italy; 4. Section of Dermatology - Istituto Dermopatico dell’Immacolata IDI-IRCCS, Rome, Italy; 5. Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyShow moreShow less
Source PDF DOI Publisher page
49 days

CDKN2A/B deletion activates c-MET dependent pro-angiogenic signaling in IDH-mutant astrocytoma

Authors
Dustin Grief; Eric Stevens; David Nascari; Joseph Loftus; Raquel Teixeira Yokoda; Nhan L. Tran; Shannon Fortin EnsignShow moreShow less
Affiliations
1. Department of Cancer Biology, Mayo Clinic Arizona, Phoenix, USA; 2. Mayo Clinic Graduate School of Biomedical Sciences, Phoenix, USA; 3. Mayo Clinic Alix School of Medicine, Phoenix, USA; 4. Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix, USA; 5. Division of Immunology and Microbiome, Translational Genomics Research Institute, Phoenix, USA; 6. Department of Hematology and Oncology, Mayo Clinic Arizona, Phoenix, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Journal of Translational Medicine take to review a manuscript?

As of 2026-11-18, CrushSCI has 20 complete review records for Journal of Translational Medicine. The fastest paper went from submission to acceptance in 2 days (ICH E21: from landmark guidance to specific action for maternal and child health, received 2026-03-16, accepted 2026-03-18); the slowest took 277 days. The average is 91.4 days and the median is 79 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.